Crossmark

Vaccine effectiveness in patients admitted for influenza during the 2023–2024 season

Crossref DOI link: https://doi.org/10.1016/j.medcle.2024.11.002

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ruzafa Martinez, Christian

Valero, Salvador

García Villalba, Eva

Tomás, Cristina

Muñoz, Ángeles

Alcaraz, Antonia

Martínez-Rodríguez, Rodrigo

Hernández, María Dolores

Martínez, María Isabel

Vicente, María Rosario

Guijarro Westermeyer, Elena

González Hipólito, Román

Bernal, Enrique
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

stm-asf valid from 2024-12-01

stm-asf valid from 2024-12-01

stm-asf valid from 2024-12-01

stm-asf valid from 2024-12-01

stm-asf valid from 2024-12-01
More Information

This article is maintained by: Elsevier

Article Title: Vaccine effectiveness in patients admitted for influenza during the 2023–2024 season

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2024.11.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2024.07.023

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.